WuXi AppTec Co. Ltd.

WUXAY | OTC

Price Alert Chart Builder DCF Calculator

$25.16

+$0.05 (+0.20%)

At close: Nov 5, 2026, 3:50 PM ET

$25.55

+$0.39 (+1.55%)

After-hours: Nov 5, 2026, 2:47 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

+0.20%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 5, 2026

73.9

Fundamentals Excellent

Market Sentiment Neutral

Moat Wide

Sector Rank #36/1024 (Top 4%)

Full Analysis

Key Statistics

Market Data

Market Cap $60.99B

1D Range

25.16 26.16

52W Range

12.45 28.00

Valuation (TTM)

PE 19.15

PB 4.95

EV/EBITDA 13.75

Valuation (NTM)

Forward PE 17.53

Forward PEG 0.37

Price Target $0.00

Cash Flow

FCF Yield 3.4%

SBC Adj. FCF Yield 3.4%

SBC Impact N/A

Margins

Gross Margin 53.2%

Operating Margin 43.0%

FCF Margin 28.2%

Growth (CAGR)

Revenue 3Y | 5Y 12.8% | 22.3%

Dil EPS 3Y | 5Y 41.5% | 44.6%

FCF 3Y | 5Y 37.1% | 44.8%

Returns

ROA 21.1%

ROE 30.8%

ROIC 18.8%

Financial Health

Net Cash

¥45.35B ($6.76B)

Current Ratio 3.43

Interest Coverage 121.99

Dividends

Div Yield 0.32%

Payout Ratio 0.8%

FCF Payout Ratio 35.3%

All Key Statistics

Loading financial charts...

Profile

WuXi AppTec Co., Ltd. functions as an investment holding entity, globally delivering a wide array of research, development, and manufacturing services. Operating across the People's Republic of China,...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 33,834

IPO Date Feb 24, 2021

Website www.wuxiapptec.com

Fiscal Year n/a

Full Company Profile

Latest News

29 days ago · prnewswire.com

WuXi AppTec Earns EcoVadis Gold Medal for Third Consecutive Year, Ranking Among Global Top 5% for Sustainability

SHANGHAI, Oct. 7, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received a Gold medal from EcoVadis for the third consecutive year, reflecting the Company's consistent commitment to sustainability. EcoVadis is a leading sustainability rating agency for global supply chains.

1 month ago · zacks.com

Recent Price Trend in Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) could be a great choice.

2 months ago · prnewswire.com

WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion

SHANGHAI, Aug. 30, 2026 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announces the distribution of its 2026 interim cash dividend.

2 months ago · zacks.com

Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) Is a Great Choice for 'Trend' Investors, Here's Why

Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks.

3 months ago · zacks.com

Here's Why Momentum in Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) Should Keep going

Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks.

Earnings

Latest Earnings

Oct 26, 2026

EPS

$0.41

Miss -5.78%

YoY: +136.88%

REV

$2.5B

Beat +4.42%

YoY: +47.43%

Next Earnings

Mar 22, 2027

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞